Mark Lemley and Lisa Larrimore Ouellette’s article, “The Medicare Innovation Subsidy”, forthcoming in the New York University Law Review, was reviewed on Jotwell in “Medicare Reimbursement for Prescription Drugs: An Overlooked Policy Lever for Innovation”

Over the past few decades, policymakers have used Medicare reimbursement policy to achieve wide-ranging changes in the health care system. Recent efforts have focused on using the levers of Medicare payments to encourage innovation in providers’ organizational structures and health care delivery. In their forthcoming article The Medicare Innovation Subsidy, Lemley, Ouellette, and Sachs consider another type of innovation influenced by Medicare reimbursement – innovation in the pharmaceutical market.